» Articles » PMID: 29022897

Cooperation of Rel Family Members in Regulating Aβ-mediated Pro-inflammatory Cytokine Secretion by Retinal Pigment Epithelial Cells

Overview
Journal Cell Death Dis
Date 2017 Oct 13
PMID 29022897
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloid-beta (Aβ) is a hallmark component of age-related macular degeneration (AMD), which induces secretion of pro-inflammatory cytokines from retinal pigment epithelium (RPE). Previous studies have shown that p50/RelA (p65), a member of NF-κB family, is an essential pro-inflammatory transcription factor responding to Aβ stimulation, but few focused on the other two Rel transcription factor members - RelB and c-Rel - and their role in Aβ-mediated inflammation. It was reported that RelA, RelB and c-Rel are also implicated in various NF-κB-mediated inflammatory diseases. Therefore, we infer that Aβ-mediated inflammation targets not only the classical inflammation regulator, RelA, but also RelB and c-Rel. In this study, we demonstrate that intravitreally injected Aβ mice develop AMD-like pathologic changes, coupled with Rel protein (RelA, RelB and c-Rel) synthesis and nuclear translocation. To focus on the interaction mechanism of Rel proteins, we found that RelB and c-Rel formed a heterodimer with RelA in mice model. We also found that c-Rel silencing decreased the levels of Aβ-dependent RelA expression, indicating that RelB and c-Rel may interact with RelA as coactivator and c-Rel is required to activate the expression of RelA. Moreover, Rel protein silencing decreased the expression of distinct pro-inflammatory cytokines. Together, we demonstrate that besides RelA, RelB and c-Rel can also be activated by Aβ, all of which mediate pro-inflammatory cytokine transcription and RPE damage. Our findings imply that RPE-mediated inflammation under the stimulation of Aβ is multi-targeted and RelA, RelB and c-Rel proteins may be the new targets of anti-inflammatory agents.

Citing Articles

Retinoic acid related orphan receptor α is a genetic modifier that rescues retinal degeneration in a mouse model of Stargardt disease and Dry AMD.

Akula M, McNamee S, Love Z, Nasraty N, Chan N, Whalen M Gene Ther. 2024; 31(7-8):413-421.

PMID: 38755404 PMC: 11257945. DOI: 10.1038/s41434-024-00455-z.


An IL-17A-centric response to Epstein-Barr virus DNA mediated by dendritic Cell-T cell interactions.

Shehab M, Hussein H, Fadlallah S, Rahal E Front Mol Biosci. 2024; 11:1243366.

PMID: 38638687 PMC: 11024278. DOI: 10.3389/fmolb.2024.1243366.


Immunoproteasome Subunit Low Molecular Mass Peptide 2 (LMP2) Deficiency Ameliorates LPS/Aβ-Induced Neuroinflammation.

Guo Y, Wang S, Li L, Zhang H, Chen X, Huang Z Mol Neurobiol. 2023; 61(1):28-41.

PMID: 37568045 DOI: 10.1007/s12035-023-03564-9.


hsa-miR-518-5p/hsa-miR-3135b Regulates the REL/SOD2 Pathway in Ischemic Cerebral Infarction.

Zhao B, Jiang X Front Neurol. 2022; 13:852013.

PMID: 35481271 PMC: 9038098. DOI: 10.3389/fneur.2022.852013.


The Traditional Chinese Medicine Hua Tuo Zai Zao Wan Alleviates Atherosclerosis by Deactivation of Inflammatory Macrophages.

Yu Z, Zheng X, Wang C, Chen C, Ning N, Peng D Evid Based Complement Alternat Med. 2022; 2022:2200662.

PMID: 35388302 PMC: 8979684. DOI: 10.1155/2022/2200662.


References
1.
Chakravarthy U, Harding S, Rogers C, Downes S, Lotery A, Wordsworth S . Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology. 2012; 119(7):1399-411. DOI: 10.1016/j.ophtha.2012.04.015. View

2.
Espinosa-Heidmann D, Suner I, Catanuto P, Hernandez E, Marin-Castano M, Cousins S . Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest Ophthalmol Vis Sci. 2006; 47(2):729-37. DOI: 10.1167/iovs.05-0719. View

3.
Shih V, Davis-Turak J, Macal M, Huang J, Ponomarenko J, Kearns J . Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways. Nat Immunol. 2012; 13(12):1162-70. PMC: 3634611. DOI: 10.1038/ni.2446. View

4.
Johnson L, Leitner W, Rivest A, Staples M, Radeke M, Anderson D . The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A. 2002; 99(18):11830-5. PMC: 129354. DOI: 10.1073/pnas.192203399. View

5.
Liu R, Gao J, Cao S, Sandhu N, Cui J, Chou C . Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013; 54(3):2225-37. PMC: 3947398. DOI: 10.1167/iovs.12-10849. View